Resultados de la búsqueda 211-220 of 1011 for Alternative

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  2. Salud de los consumidores Multimedia - Mayo Clinic

    Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Medicine. https://nccih.nih.gov ...

  3. Salud del adulto - Mayo Clinic

    De Mayo Clinic a tu buzón. Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad ...

  4. Salud de los consumidores Multimedia - Mayo Clinic

    Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Medicine. https://nccih.nih.gov ...

  5. Salud de los consumidores Multimedia - Mayo Clinic

    Complementary, alternative, or integrative health: What's in a name? National Center for Complementary and Integrative Medicine. https://nccih.nih.gov ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for these disorders. SULF1 ...

  10. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...